Tag: Nivolumab+AVD

Adaptive interim PET-CT guides treatment for advanced Hodgkin’s lymphoma

Nivolumab+AVD improves progression-free survival in advanced-stage Hodgkin lymphoma

byMichaela Dowlingand1 others

November 21, 2024

1. This randomized controlled trial found that in patients with newly diagnosed stage III or IV Hodgkin lymphoma, treatment with ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

Fluoxetine may improve hemodynamic status and organ dysfunction in patients with severe sepsis
Home longevity scales generate data that outruns clinical evidence
Perioperative esketamine may improve postoperative pain and mood outcomes after cesarean section

No Result

View All Result